80 Matching Annotations
  1. Jun 2017
    1. releases its negative RNA into the cytoplasm, RSV replicase begins base pairing to form the positive RNA template strand

      RSV REPLICATION MECHANISM

    2. after it enters the body through a mucous membrane, like the eye or nos

      RSV Portal of Entry

    3. SV is often considered a nosocomial infection due to its prevalence in hospital settings, ranging from 6-56% from neonatal/pediatric to adult settings

      RSV NOSOCOMIAL SPREAD

    4. human contact from the spread of infected respiratory secretions like mucous

      RSV Mode of Transmission

    1. The first step is to transcribe a positive sense RNA strand from the original negative sense RNA strand

      EBOLA REPLICATION MECHANISM

    2. Ebola enters the human host via mucosal areas or skin abrasions.

      EBOLA Portal of Entry

    3. The primary reservoir of Ebola is thought to be fruit bats. It is not fully understood how Ebola jumped species.

      EBOLA Resevoir

    4. Lastly, health-care providers who treat Ebola-infected patients are at high risk of contamination, as infections have occurred in the past when precautions were not strictly enforced

      Ebola - NOSOCOMIAL SPREAD

    5. bola originally jumped to the human species from close contact with fruit bats, their excretions, or their blood (5). After that, transmission is through human-human contact, more specifically through direct contact with bodily fluids and/or anything carrying these fluids

      Ebola Mode of Transmission

    1. encode accessory proteins (p12, p13/p30), the Rex post-transcriptional regulator (ORF III) and the Tax protein (ORF IV).
    2. In addition to the essential viral genes gag, prt, pol, and env, HTLV-1 encodes regulatory and accessory genes for the pX region open reading frames (ORFs), which are located between the env gene and the 3’ portion of the viral genome.
    3. HTLV-1 contains a linear, dimeric, ssRNA(+) genome of 8,507nt , with a 5’-cap and a 3’poly-A tail
  2. May 2017
    1. Primary advantages over an ampicillin-gentamicincombination are its narrower spectrum of antimicrobial activity and lower cost. However, high doses of penicillin G must be used for the treatment of Group B streptococcal disease for two reasons. First, the MIC of penicillin G for Group B Streptococcus is relatively high, 4-10 fold greater (range 0.01-0.4 µg/ml) than that for group A streptococcal strains

      Antibiotic treatment for Strep B

  3. Apr 2017
    1. Although some necrotizing infections may still be susceptible to penicillin, clindamycin is the treatment of choice for necrotizing infections

      Why clindamycin is treatment of choice for NF infections**

    2. If staphylococci or gram-negative rods are involved, vancomycin and other antibiotics to treat gram-negative organisms other than aminoglycosides may be required
    3. For example, use may depend on whether a nasocranial infection is present, or it may need to be avoided in patients who are likely to be carriers of MRSA (eg, those with diabetes, those who use illicit drugs, those undergoing hemodialysis).
    4. A more specifically targeted antibiotic regimen may be begun after the results of initial gram-stained smear, culture, and sensitivities are available.

      MORE SPECIFIC REGIMEN after microbe indentification

    5. Empiric antibiotics should be started immediately. Initial antimicrobial therapy should be broad-based, to cover aerobic gram-positive and gram-negative organisms and anaerobes. A foul smell in the lesion strongly suggests the presence of anaerobic organisms. The maximum doses of the antibiotics should be used,

      CONSIDERATIONS IN TREATING NF WITH ANTIBIOTICS

    1. The activities of cefotaxime, moxalactam, MK 0787 (N-formimidoyl thienamycin), ampicillin, oxacillin, vancomycin, and clindamycin were compared against gram-positive cocci.

      EFFECTIVENESS of vancomycin on gram positive cocci

    1. Data from retrospective studies[138,139] and one observational prospective study[140] of patients with severe pneumococcal bacteremia have suggested that combination therapy may be associated with reduced mortality, as compared with β-lactam monotherapy, irrespective of the level of resistance to penicillins.

      Combination theraphy indicated to be useful for S. pneumoniae even without resistance to penicillin

    2. Other alternative drugs include the carbapenems, newer quinolones, clindamycin, telithromycin, linezolid, and vancomycin

      Alternative antibiotics for S. pneumoniae

    3. In critically ill patients, cefotaxime or ceftriaxone is most often the primary alternative if there is no indication of a type 1 allergy to penicillin

      Alternative for S. pneumonia if allergy to penicillin

    4. The majority of strains with reduced susceptibility to penicillin are more susceptible to certain third-generation cephalosporins, such as cefotaxime or ceftriaxone, but there is always some cross-resistance within the β-lactam group, and resistance to these drugs is increasing

      Strains with resistance to penicillin treated with 3rd generation CEPAHLOSPORINS such as CEFOTAXIME/CEFTRIAXONE but resistance is also increasing (numbers??)

    5. Penicillin remains the drug of choice for fully sensitive strains with minimum inhibitory concentration (MIC) < 0.1 µg/L. Also strains with moderately decreased susceptibility (MIC 0.1-1.0 µg/L) can be effectively treated with penicillin G, provided that the dose and dosing intervals are adequate

      Effectiveness of penicillin on S. pneumoniae (VIRIDANS)

  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    1. These casereports suggest the following risk factors for the development ofpneumococcal NF – a history of diabetes, systemic lupuserythematosus, immunosuppression, alcohol use, coronaryartery disease and administration of intramuscular nonsteroidalanti-inflammatory drugs (NSAIDs)

      Causes of NF by S. pneumoniae

    1. 1. Vancomycin, Clindamycin, and Piperacillin/ tazobactam 2. Linezolid and Piperacillin/tazobactam
    2. The recommended course of treatment is the use of vancomycin, linezolid, or daptomycin to treat MRSA and gram-positive bacteria, an agent to treat anaerobic bacteria (e.g., clindamycin), and an agent to treat gram-negative bacteria. Alternatively, anaerobic and gram-negative bacteria can be treated with one drug that covers both

      Antibiotic regimen for NF

    1. Lincosamide for treatment of serious skin and soft-tissue staphylococcal infections

      Effective for soft tissue infections ***

    2. Resistance is obtained as part of a cassette of genetic information, or a transposon, that encodes resistance to multiple antibiotics.

      Mechanism of resistance

    1. Transposon transfer is thought to be the most likely mechanism in S pneumoniae , although point mutations also occur.

      Mechanism of action

    2. Even cefotaxime and ceftriaxone resistance has been documented

      Antibiotic resistance of S. pneumoniae

    3. The capsule of S pneumoniae renders it resistant to phagocytosis

      Virulence: persistence, immune evasion

    1. neumolysin is produced as a 52 kDa soluble protein that oligomerizes in the membrane of target cells to form a large ring-shaped transmembrane pore. The pore is 260 Å in diameter and is composed of approximately 40 monomer subunits. During its conversion from a soluble monomer to a membrane-inserted oligomer, pneumolysin undergoes a series of spectacular structural changes42. The oligomers are thought to be responsible for the cytolytic activity of the toxin and the plethora of cell-modulatory activities that are evident at sub-lytic con-centrations. These activities include: inhibition of ciliary beating on respiratory epithelium and brain ependyma; inhibition of the phagocyte respiratory burst; and induc-tion of cytokine synthesis and CD4+ T-cell activation and chemotaxis43,44. Site-directed mutagenesis has shown that pneumolysin activates the classical complement pathway independently of its cell-modulatory activity45

      possible mechanism of protein virulence

    2. lmost all pneumococcal CPSs are negatively charged, which could increase their repulsion of the sialic acid-rich mucopolysaccharides that are found in mucus12
    3. The pneumococcus resides on the mucosal surface of the upper respiratory tract
    4. one of the common forms of pneumococcal disease, however, promote pneumococcal transmission, which implies that the virulence characteristics of the pneumococcus are prob-ably adaptations that increase its persistence within a host during colonization
    5. Although colonization at this site seems to be asymptomatic, if the organism gains access to the normally sterile parts of the airway a rapid inflamma-tory response ensues that results in disease.
    1. 5 days to 5 months after initial exposure to Brucella species

      Ask about traveling history/dairy consumption for at least 6 months, possibly a year?

    2. initial symptoms(https://www.cdc.gov/brucellosis/symptoms/index.html) are non-specific

      Means narrowing down before concluding Bru, need context especially risk of exposure

    1. wild hogs (feral swine) elk bison caribou moose

      Have they been in areas where this would be common (if they haven't participated themselves)?

    1. Laboratory tests and a short course of antibiotics

      Bacterial! Harmful to unborn children, therefore need to provide prophylaxis if this is possible/likely

    1. y unknowingly consume unpasteurized dairy products.

      Be skeptical if they have traveled to these areas but report not consuming dairy products - may not realize they have consumed products

    2. Unpasteurized cheeses (sometimes called "village cheeses

      Have you consumed dairy products outside/from outside of the US recently? (how long ago?)

    1. slaughterhouse workers meat-packing employees veterinarians laboratory workers

      Do you work with/around animals or animal remains?

    1. lthough brucellosis can be found worldwide, it is more common in countries that do not have effective public health and domestic animal health programs.

      Have you traveled to any of these countries recently? (In the past year, 6 months, etc.?)

    1. Some signs and symptoms may persist for longer periods of time

      Duration of symptoms? Severity of symptoms? Can help determine when it's onset

    1. index cases

      typically hard to even identify

    2. incorrect impression about how the disease emerges in the first place and, on the other hand, insinuate that somebody should be blamed for this outbreak,
    3. understand index cases so that we know how diseases are coming into a community and how to stop their spread.

      even though they are hard to identify, they are still very important if not critical to the spread of disease

    4. primary cases

      INDEX CASE: first documented case -versus- PRIMARY CASE: first organisms that brings the bacteria/virus into a population

    5. "It is not uncommon for infectious agents to percolate in the environment for years or even decades without detection,"
    6. super-spreaders
    7. bacterium Salmonella typhi.

      Salmonella Typhi = typhoid fever Salmonella Typhimurium = was the most common cause of food poisoning, now second to Entertiditis - causes typhoid-like symptoms in mice but non-fatal symptoms in humans Salmonella Entertiditis = most common cause of food poisoning in the last 20 years, very good at infection chickens without causing symptoms, so the bacteria spreads from hen to hen very quickly

    8. who for one reason or another may be infected with a pathogen and not have that many symptoms but can shed that pathogen in a way that makes it infectious to other people
    9. No one really knows whether Mallon was the true patient zero in the typhoid case or simply a super-spreader or super-shedder.
    10. I can't even think of a time when we've actually known an index case,"
    11. "You wouldn't call him 'patient zero,' but if you consider his impact in terms of the outbreak, he was critical in the spread of the disease,"

      someone may have had it before him, but he was critical in spreading the disease - why patient zero is not really helpful. Index and primary case identification have more significance.

    12. In less than four months, about 4,000 cases and 550 deaths from SARS could be traced to Liu's stay in Hong Kong.
    13. The hospital where he worked treated SARS, and Liu might have come into contact with the virus through a patient.
    14. "There are plenty of potential patient zeroes out there that get infected with stuff,"
    15. The key to an outbreak, Friedrich said, is for those viruses to be transmitted from a single person to more people.

      single person to multiple people around the same time, just just from one person to another, to another

    16. In 2004, a 6-year-old boy named Captain Boonmanuch became the first confirmed casualty of bird flu in Thailand as the virus spread across Asia,
    17. "The viruses that really circulate in humans turn out mostly to be reassortants between viruses, usually from birds and other human viruses."

      virus changes as it goes from host to host (often different species)

    18. A reassortant
    19. Avian influenza viruses don't replicate well in humans, human influenza viruses don't replicate well in birds, but if a bird virus and a human virus gets into a pig, you can have reassortment and get totally new strains out,
    20. H1N1 influenza emerged in humans to cause a pandemic in 1918, Friedrich said, and then a similar pandemic hit the world in 2009.
    21. It is believed that, leading up to the 2009 pandemic, pigs became infected with a few different viruse

      reassortant virus, not derived from just one source

    22. The resulting outbreak serves as an example of how new flu viruses might enter the human population, Friedrich said.

      goes through multiple organisms, changes, and then becomes the virus that makes us sick

    23. Ebola can be introduced into the human population through close contact with the blood, secretions, organs and other bodily fluids of infected animals
    24. Officials said he might have contracted the disease from a bat.
    25. he virus continued to spread through contact with the body and with human bodily fluids, possibly even after the human died
    26. Last year, there was a MERS outbreak in South Korea, and a 68-year-old man with an extensive travel history was reported to be the so-called patient zero.
    27. He was not ill with symptoms during his travels, according to the WHO, but once he fell ill, he went to the Samsung Medical Center in Seou

      May still have been infectious before symptoms showed, could have spread during travels before becoming ill

    28. They happened to be in the wrong place at the wrong time."
    29. it's not that tight. It's not that clean.

      Zoonotic source, reassortment, microbe environment/needs, etc. all contribute to how the disease is spread and how quickly

    30. it's not that tight. It's not that clean.
    31. "As humans, we sort of want to make tight stories about things, and sometimes that involves blaming or saying, 'Oh, this person started the epidemic,'